Measurement of Cerebral Oxygenation Using NIRS Method in the Preterm Infants With Intracranial Haemorrhagia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Zekai Tahir Burak Maternity and Teaching Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier:
NCT01266889
First received: December 6, 2010
Last updated: December 23, 2010
Last verified: December 2010

December 6, 2010
December 23, 2010
December 2010
March 2011   (final data collection date for primary outcome measure)
cerebral oxygenation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01266889 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Measurement of Cerebral Oxygenation Using NIRS Method in the Preterm Infants With Intracranial Haemorrhagia
Not Provided

The aim of the study was investigated the cerebral tissue oxygenation index (c-TOI) measured by near infrared spectroscopy (NIRS)in the preterm infants with intracranial haemorrhagia.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

primer care clinic

Cerebral Oxygenation, Intracranial Haemorrhagia
Device: device:INVOS 5100
Continuous wave NIRS is a method for measurement of cerebral oxygenation and haemodynamics. This method is non-invasive, continuous, and can also be used as bedside monitoring. With continuous wave NIRS only changes in concentration of oxyhaemoglobin (O2Hb) and deoxyhaemoglobin (HHb) can be measured, not the absolute level of these parameters. It has been shown that changes in concentration of HbD (O2Hb - HHb) reflect changes in CBF. So, continuous monitoring of changes in concentration of HbD can be used as an indicator of changes in CBF, but changes in CBV will also influence the HbD signal, as will changes in arterial O2 saturation (saO2) and changes in cerebral metabolic rate for oxygen.
study group, control group
Intervention: Device: device:INVOS 5100
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
May 2011
March 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

.<34 gestation week preterm infants with intracranial haemorrhagia

Exclusion Criteria:

  • sepsis
  • NEC
  • congenital abnormalities
  • hydrocephalus
  • intracranial infections
Both
up to 3 Days
No
Contact: ugur dilmen, proff +90 312 506 5270 ugurdilmen@gmail.com
Turkey
 
NCT01266889
3
Yes
Zekai Tahir Burak Maternity and Teaching Hospital
Zekai Tahir Burak Maternity and Teaching Hospital
Not Provided
Not Provided
Zekai Tahir Burak Maternity and Teaching Hospital
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP